TetraLogic Pharmaceuticals
TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that discovers and develops small molecule drugs that modulate programmed cell death pathways to treat debilitating diseases and conditions. The company’s Smac Mimetics...Homepage: http://www.tetralogicpharma.com/
Total money raised: $66M
19355
343 Phoenixville Pike
Malvern
USA PA
Malvern
USA PA
Phone: 610.889.9900
Updated on May 24, 2011
TetraLogic Pharmaceuticals at CrunchBase
John M. Gill Founder, President, CEOTetraLogic Pharmaceuticals at CrunchBase
Past
May, 2011
TetraLogic Pharmaceuticals raised $6M in a Series C round from Nextech Venture
TetraLogic Closes $6 Million Series C-1 Investment with Nextech Invest Ltd 
streetinsider.com
January, 2011
TetraLogic Pharmaceuticals raised $23M in a Series C round
TetraLogic Pulls Down $23M Series C Tranche For Cancer Trials 
fis.dowjones.com
September, 2010
TetraLogic Pharmaceuticals raised $5M in a Series C round from Pfizer Venture Investments
TetraLogic Pharma Boosts Series C To $37M With Pfizer Ventures Capital fis.dowjones.com
August, 2010
TetraLogic Pharmaceuticals raised $32M in a Series C round from Clarus Ventures, Hatteras Venture Partners, Amgen Ventures, HealthCare Ventures, Latterell Venture Partners, Novitas Capital , Quaker BioVentures, and The Vertical Group
TetraLogic nabs $32M round for lead cancer therapy Read more: TetraLogic nabs $32M round for lead cancer therapy 
fiercebiotech.com